112 related articles for article (PubMed ID: 2609767)
1. [The esterase activity of the peripheral blood in patients with foot mycoses].
Svirid SG
Vestn Dermatol Venerol; 1989; (9):56-8. PubMed ID: 2609767
[TBL] [Abstract][Full Text] [Related]
2. [The nonspecific correction of phagocytosis in patients with foot mycoses].
Svirid SG
Vrach Delo; 1989 Nov; (11):99-100. PubMed ID: 2609600
[TBL] [Abstract][Full Text] [Related]
3. [Esterase activity of the peripheral blood phagocytes and its nonspecific correction in patients with rubromycosis pedis].
Svirid SG; Vlasenko VV; Svirid AA
Vrach Delo; 1988 Jul; (7):92-3. PubMed ID: 3188485
[No Abstract] [Full Text] [Related]
4. [Diucifon in the treatment of chronic aphthous stomatitis].
Terekhova NV; Lialina MI; Khazanova VV; Zemskaia EA; Zidra SI
Stomatologiia (Mosk); 1986; 65(1):20-1. PubMed ID: 3456657
[No Abstract] [Full Text] [Related]
5. [Oxygen-dependent phagocytosis in patients with tinea pedis during treatment].
Svirid SG
Vestn Dermatol Venerol; 1990; (8):67-9. PubMed ID: 2256388
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effectiveness of diucifon in acute pneumonia based on clinico-immunological and bronchoscopic study data].
Ermakov EV; Kolomoets NM; Novozhenov VT; Gorlina NK; Leskov VP
Ter Arkh; 1983; 55(3):41-7. PubMed ID: 6344302
[No Abstract] [Full Text] [Related]
7. [Clinico-immunologic aspects of patients with chronic obstructive bronchitis. Immunomodulating therapy].
Martsinovskiĭ VIu; Sil'vestrov VP; Karaulov AV
Ter Arkh; 1983; 55(12):61-4. PubMed ID: 6607547
[No Abstract] [Full Text] [Related]
8. [Possible use of diucifon in true eczema].
Kubanova AA; Vadil'eva LL; Petrova IV; Leshchenko GM
Vestn Dermatol Venerol; 1983 Dec; (12):24-6. PubMed ID: 6369823
[No Abstract] [Full Text] [Related]
9. [Clinico-immunologic substantiation of the use of diucifon in patients with chronic tonsillitis].
Konstantinova NP; Belokrinitskiĭ DV; Kochetova SV; Shelepin AA
Vestn Otorinolaringol; 1985; (6):49-52. PubMed ID: 3879034
[No Abstract] [Full Text] [Related]
10. [Immunologic changes and their correction in different forms of acute cholecystitis in late middle-age and the aged].
Zatevakhin II; Krylov LB; Mamatkulov SM; Sabirov BU; Akhtamov DA
Khirurgiia (Mosk); 1985 Feb; (2):84-7. PubMed ID: 3981944
[No Abstract] [Full Text] [Related]
11. [Effects of diucifon on immunological indicators and dynamics of the cutaneous process in eczema patients].
Kubanova AA; Vasil'eva LL
Vestn Dermatol Venerol; 1984 May; (5):13-5. PubMed ID: 6610995
[No Abstract] [Full Text] [Related]
12. [Neutrophil chemotactic activity in syphilis patients during treatment].
Borisenko KK; Lezvinskaia EM; Basinskaia NM; Mikheev NA
Vestn Dermatol Venerol; 1985 Apr; (4):57-9. PubMed ID: 4002850
[No Abstract] [Full Text] [Related]
13. [The glycolytic status of peripheral blood phagocytes and its therapeutic correction in patients with foot mycoses].
Leshchenko VM; Svirid SG
Vestn Dermatol Venerol; 1989; (7):8-10. PubMed ID: 2816024
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal immunopharmacotherapy in patients with chronic septic cholangitis.
Khaitov RM; Galperin EI; Podobin NP; Leskov VP; Fedenko ES; Prosorovsky NS; Akhaladze GG; Prokopenko VP
Hepatogastroenterology; 1993 Apr; 40(2):126-30. PubMed ID: 8509042
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the effectiveness of diucifon in rheumatoid arthritis and systemic scleroderma].
Abdrakhmanova RSh; Bilich IL; Mangusheva MM; Bombina LK; Khalfieva GM
Ter Arkh; 1986; 58(7):101-3. PubMed ID: 3532398
[No Abstract] [Full Text] [Related]
16. [Neutrophil peroxidase activity in the peripheral blood of patients with rubromycosis of the feet].
Fedorenko AE; Svirid SG
Vrach Delo; 1986 Dec; (12):83-4. PubMed ID: 3029997
[No Abstract] [Full Text] [Related]
17. [Correlation of the cyclic nucleotide and calcitonin levels and the cellular immunity indices in true eczema patients].
Kubanova AA; Vasil'eva LL; Zolotukhin SV; Suchkova ShN
Vestn Dermatol Venerol; 1984 Jul; (7):16-20. PubMed ID: 6089468
[No Abstract] [Full Text] [Related]
18. [Diucifon in the therapy of dermatoses].
Grebeniuk VN; Fedorova EG; Sheklakova MN
Vestn Dermatol Venerol; 1980 Feb; (2):41-3. PubMed ID: 6986724
[No Abstract] [Full Text] [Related]
19. The efficiency of chemotherapy with immunomodulators for patients with destructive lung tuberculosis.
Khomenko AG; Insanov AB
Z Erkr Atmungsorgane; 1986; 167(1-2):163-7. PubMed ID: 3765712
[TBL] [Abstract][Full Text] [Related]
20. [Comparative characteristics of immunomodulators in the combined treatment of patients with mandibular fractures].
Zuev VP; Evglevskaia IuP; Tikhonova GB
Stomatologiia (Mosk); 1985; 64(2):34-6. PubMed ID: 3873727
[No Abstract] [Full Text] [Related]
[Next] [New Search]
